Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Clinical trial NCT01333462 · COMPLETED

Trial details

NCT number: NCT01333462
Sponsor: NanoBio Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Volunteers

Start date: 2009-03-01
Primary completion: 2009-08-01
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.